Oncolytic viral therapy for pancreatic cancer: current research and future directions
- PMID: 27512661
- PMCID: PMC4918362
- DOI: 10.2147/OV.S53858
Oncolytic viral therapy for pancreatic cancer: current research and future directions
Abstract
The development of targeted agents and chemotherapies for pancreatic cancer has only modestly affected clinical outcome and not changed 5-year survival. Fortunately the genetic and molecular mechanisms underlying pancreatic cancer are being rapidly uncovered and are providing opportunities for novel targeted therapies. Oncolytic viral therapy is one of the most promising targeted agents for pancreatic cancer. This review will look at the current state of the development of these self-replicating nanoparticles in the treatment of pancreatic cancer.
Keywords: oncolytic virus; pancreatic cancer; review.
Figures
Similar articles
-
Future directions: oncolytic viruses.Clin Lung Cancer. 2004 Jan;5(4):226-30. doi: 10.3816/CLC.2004.n.003. Clin Lung Cancer. 2004. PMID: 14967074 Review.
-
Potent antitumor effect of neurotensin receptor-targeted oncolytic adenovirus co-expressing decorin and Wnt antagonist in an orthotopic pancreatic tumor model.J Control Release. 2015 Dec 28;220(Pt B):766-82. doi: 10.1016/j.jconrel.2015.10.015. Epub 2015 Oct 22. J Control Release. 2015. PMID: 26471393
-
Experimental Evolution Generates Novel Oncolytic Vesicular Stomatitis Viruses with Improved Replication in Virus-Resistant Pancreatic Cancer Cells.J Virol. 2020 Jan 17;94(3):e01643-19. doi: 10.1128/JVI.01643-19. Print 2020 Jan 17. J Virol. 2020. PMID: 31694943 Free PMC article.
-
The potential of oncolytic virus therapy for pancreatic cancer.Cancer Gene Ther. 2005 Sep;12(9):725-36. doi: 10.1038/sj.cgt.7700830. Cancer Gene Ther. 2005. PMID: 15818382 Review.
-
Advances in the mechanisms of action of cancer-targeting oncolytic viruses.Oncol Lett. 2018 Apr;15(4):4053-4060. doi: 10.3892/ol.2018.7829. Epub 2018 Jan 19. Oncol Lett. 2018. PMID: 29541169 Free PMC article.
Cited by
-
Natural Killer Cells: Diverse Functions in Tumor Immunity and Defects in Pre-neoplastic and Neoplastic Stages of Tumorigenesis.Mol Ther Oncolytics. 2019 Nov 29;16:41-52. doi: 10.1016/j.omto.2019.11.002. eCollection 2020 Mar 27. Mol Ther Oncolytics. 2019. PMID: 31930165 Free PMC article. Review.
-
Oncolytic virus-mediated reducing of myeloid-derived suppressor cells enhances the efficacy of PD-L1 blockade in gemcitabine-resistant pancreatic cancer.Cancer Immunol Immunother. 2023 May;72(5):1285-1300. doi: 10.1007/s00262-022-03334-x. Epub 2022 Nov 27. Cancer Immunol Immunother. 2023. PMID: 36436021 Free PMC article.
-
Viro-immune therapy: A new strategy for treatment of pancreatic cancer.World J Gastroenterol. 2016 Jan 14;22(2):748-63. doi: 10.3748/wjg.v22.i2.748. World J Gastroenterol. 2016. PMID: 26811622 Free PMC article. Review.
-
Editorial announcing PubMed indexing of Oncolytic Virotherapy.Oncolytic Virother. 2017 Feb 15;6:19-20. doi: 10.2147/OV.S128720. eCollection 2017. Oncolytic Virother. 2017. PMID: 28243580 Free PMC article. No abstract available.
-
Bone marrow mesenchymal stem cells-derived exosomes for penetrating and targeted chemotherapy of pancreatic cancer.Acta Pharm Sin B. 2020 Aug;10(8):1563-1575. doi: 10.1016/j.apsb.2019.11.013. Epub 2019 Nov 28. Acta Pharm Sin B. 2020. PMID: 32963950 Free PMC article.
References
-
- Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10–29. - PubMed
-
- Stathis A, Moore MJ. Advanced pancreatic carcinoma: current treatment and future challenges. Nat Rev Clin Oncol. 2010;7(3):163–172. - PubMed
-
- American Cancer Society . Cancer Facts and Figures 2013. Atlanta: American Cancer Society; 2013. [Accessed August 1, 2013]. Available from: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/docume....
-
- Bilimoria KY, Bentrem DJ, Ko CY, et al. Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database. Cancer. 2007;110(4):738–744. - PubMed
-
- Allison DC, Piantadosi S, Hruban RH, et al. DNA content and other factors associated with ten-year survival after resection of pancreatic carcinoma. J Surg Oncol. 1998;67(3):151–159. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources